Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
56 hedge funds and large institutions have $111M invested in Repare Therapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 8 closing their positions.
200% more call options, than puts
Call options by funds: $3K | Put options by funds: $1K
0% less capital invested
Capital invested by funds: $112M → $111M (-$170K)
3.31% less ownership
Funds ownership: 79.59% → 76.29% (-3.3%)
8% less funds holding
Funds holding: 61 → 56 (-5)
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAA
Affinity Asset Advisors
New York
|
+$571K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$120K |
| 3 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$107K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$97.7K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$69.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.98M |
| 2 |
Millennium Management
New York
|
-$481K |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$397K |
| 4 |
Morgan Stanley
New York
|
-$326K |
| 5 |
CC
Corton Capital
Carrying Place,
Ontario, Canada
|
-$248K |
RPTX Hedge Fund Activity: Q3 2024 in Review
56 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q3 2024, worth a combined $111M — down 0.15% from $112M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of RPTX and 3 opened new positions — a net loss of 5 holders — while 18 trimmed existing stakes and 16 added.
The largest buyer was Affinity Asset Advisors, opening a new position worth an estimated $571K. The largest seller was Deep Track Capital, exiting entirely with an estimated $2.98M sold.
- 56 institutional investors held Repare Therapeutics (RPTX) as of Q3 2024, down from 61 in Q2 2024.
- Funds reported $111M of Repare Therapeutics stock for Q3 2024, down 0.15% quarter-over-quarter.
- 3 funds opened new Repare Therapeutics positions in Q3 2024 and 8 closed out, a net change of -5 holders.
- The largest Repare Therapeutics buyer in Q3 2024 was Affinity Asset Advisors, an estimated $571K added.
- The largest Repare Therapeutics seller in Q3 2024 was Deep Track Capital, an estimated $2.98M sold.
Based on aggregated 13F filings for Q3 2024.